Prosecution Insights
Last updated: November 04, 2026
Application No. 18/431,369

METHOD AND COMPOSITIONS FOR THE CONTROL OF SOME PESTS

Final Rejection §102§103§112
Filed
Feb 02, 2024
Priority
Aug 05, 2021 — continuation of PCTIB2021057201 +1 more
Examiner
KETCHAM, KAREN A
Art Unit
1614
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Future-Tense Technol Devel & Entrepreneurship Ltd.
OA Round
2 (Final)
21%
Grant Probability
At Risk
3-4
OA Rounds
9m
Est. Remaining
61%
With Interview

Examiner Intelligence

Grants only 21% of cases
21%
Career Allowance Rate
12 granted / 57 resolved
-38.9% vs TC avg
Strong +40% interview lift
Without
With
+39.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
45 currently pending
Career history
120
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
56.7%
+16.7% vs TC avg
§102
12.7%
-27.3% vs TC avg
§112
21.5%
-18.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 57 resolved cases

Office Action

§102 §103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Status of the Claims Claims 1-7 are pending. Claims 1-6 have been amended. Claim 7 was newly added. Claims included in the prosecution are claims 1-7. Withdrawn Objections/Rejections The objections to claims 1-6 are withdrawn. In light of the new amendments and/or upon further consideration, the rejection of claims 2 and 5-6 under 35 U.S.C. § 112(b) as being indefinite is withdrawn. New Rejections Applicants’ amendments have necessitated the following grounds of rejection: Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 5-6 and dependent claims thereof are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The term “effective” in claim line 3 of is a relative term which renders the claim indefinite. The term “effective” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1, 3, and 7 are rejected under 35 U.S.C. § 102 (a)(2) as being clearly anticipated by Nho et al. (KR 101226102B1 Pub. 01-24-2013) evidenced by PubChem (Potassium Alum, National Center of Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/Potassium-Alum). Citations from Nho are taken from the machine translated document provided. deemed Nho teaches the preparation of an inorganic salt wherein a liquid composition is formed from by dissolving 0.1-50 weight% of aluminum, 0.1-1 weight% of polyacrylic acid, 0.1-1 weight% of cyclodextrin in purified water (abstract). Nho anticipates the claims by teaching alum (aluminum potassium sulfate), and polyacrylic acid (paragraph [0010]). Nho teaches that the chemical component is (KAl(SO4)2 12H2O) and that aluminum is known to have antibacterial and insecticidal effects (paragraph [0016]). As polyacrylic acid (PAA) is taught, the limitation of claim 3 is anticipated and thereby anticipates the water-soluble polymer of claim 1. The metal ion taught is aluminum. Further evidenced by PubChem, the (KAl(SO4)2 12H2O) taught has metal ions (see Description section of the document provided). Nho provides examples in which polyacrylic acid, cyclodextrin and aluminum sulfate were dissolved in purified water at a ratio of 0.1% by weight, 0.1% by weight and 0.1% by weight, respectively, to prepare an aqueous solution ([0036]). Nho also provides examples of aqueous solutions of aluminum sulfate dissolved in purified water at different ratios ([0038]-[0044]) to clearly anticipate the recited “an aqueous solution of metal ions” of claim 1. Claims 1-3 are rejected under 35 U.S.C. § 102 (a)(2) as being anticipated by Rohrer et al. (US 10407353 B2, issued 09/10/2019) evidenced by Giovanni et al. (Exploring a sustainable solution to control Xylella fastidiosa subsp. Pauca on olive in the Salento Peninsula, Southern Italy. Crop Protection 139 (2021) 105288, pages 1-10). Rohrer discloses a formulation for an aqueous micronutrient fertilizer dispersion composition for both immediate and sustained release of active components within a hydrated polyelectrolyte solution (abstract). The composition is comprised of an insoluble micronutrient, a soluble micronutrient, a polyelectrolyte and a metal complexing agent (claim 1). Rohrer describes complexing agent, e.g., citric acid, throughout comprising chelators thereby disclosing a chelated metal (claim 1). As evidenced by Giovanni, zinc, copper are complexed with citric acid (i.e., bio complex Dentamet®) (page 2, column 1, paragraph 6). This formulation is very shelf stable, easily diluted, non-hard packing and highly concentrated (col. 1, lines 56-61). Rohrer teaches that the metal complexing agent renders the ions inert (col. 2, line 4). Rohrer teaches that the micronutrients in the formulation may be one or more of the following: B, N, Mg, Al, Si, P, S, Cl, K, Ca, Cr, Mn, Fe, Co, Ni, Cu, Zn, Se, Mo, Ag, Sn, I , or mixtures thereof (col. 4, lines 9-12). The polyelectrolyte is a polymer that may be soluble in water (col. 5, line 63) to include polyacrylic acid (col. 6, line 23; claim 1). Rohrer teaches that the metal complexing agent is added to the aqueous micronutrient fertilizer composition and forms a complex with a metal (col. 6, lines 49-50 and 54). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. § 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. § 103 (a) are summarized as follows: Determining the scope and contents of the prior art. Ascertaining the differences between the prior art and the claims at issue. Resolving the level of ordinary skill in the pertinent art. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicants are advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. § 102(b)(2)(C) for any potential 35 U.S.C. § 102(a)(2) prior art against the later invention. Claims 1-7 are rejected under 35 U.S.C. § 103 as being unpatentable over Tsivion et al. (WO 2020/110110 A1) in view of Xing et al. (CN 103435424 B, pub. 03/30/2016). Citations from Xing are taken from the translation provided. Tsivion discloses a compositions for suppressing the population of various pentatomid bugs and fertilizers containing chelated or non-chelated heavy metals known to be otherwise deleterious to bacteria and or fungi (paragraph [005], claims 1-3 and 6). Tsivion discloses commercially available micronutrients that comprise copper, zinc and citric acid bio complex (i.e., Dentamet®, copper and zinc combination with citric acid as a complexant) (paragraphs [013], [021]). Here the complexation and use of citric acid as a chelator reads on the chelated limitation of claim 2. Tsivion provides exemplary treatments using mixtures of nutritive heavy metal chelated with organic acids were tested for their effect in suppressing stink bug populations (paragraph [009]) which continues to read on the pentatomid insects limitation of claim 5. Regarding claims 5, Tsivion teaches pentatomid pest as stink bug (page 3, lines 13, 22). Regarding claim 6, Tsivion teaches the symbiotic bacteria maternal stink bug secretions (see pg. 2, lines 13-23) and further teaches the addition of poly-1-p-menthene-based pesticide additive to increase active ingredients penetration of maternal secretions (paragraph [013]) to read on the bacteria limitation. Regarding claims 5 and 6, with respect to being effective and considering the 112-issue discussed above, Tsivion discloses that corrected mortality rates were calculated using art-known methods to compute the effectiveness (paragraph [019]). Regarding claim 7, Tsivion teaches adding of water (paragraph [020] see water + additive, Table 1; claim 1) reads on the solution limitation. In paragraph [014], eggs are treated with the “active substances solutions” using a hand sprayer. Tsivion differs from the claimed invention insofar water-soluble polymers are not taught. However, Xing discloses a novel coating material with unique water solubility that is efficient, environmentally friendly, and economical and is directed to slow-release fertilizers (paragraph [0011], [0032]). Xing discloses that the coating material contains polymeric micro/ nanoparticles, preferably comprising ethylene-vinyl acetate copolymer and its blended polymer alloys; polyvinylpyrrolidone (PVP) and its complexed trace elements and drugs; and polymeric micro/nanoparticles (paragraph [0015], claim 1). The ethylene-vinyl acetate copolymer polymer is selected from at least one of a group that includes polyacrylic acid (PAA) and polymethacrylic acid (PMAA) (paragraph [0018], claim 4). Xing teaches that trace elements complexed with PVP include zinc and copper (paragraph [0022]). It would have been prima facie obvious to a person of ordinary skill in the art, ahead of the effective filing date of the claimed invention, to utilize the PAA and PMAA taught by Xing in the compositions of Tsivion with expected results. One would be motivated to do so with a reasonable expectation of success because Xing overcomes the challenges of release profiles of fertilizer nutrients in the art to prolong or control the release of fertilizer nutrients and coordinate the release of nutrients with the nutrient requirements of crops, thereby improving fertilizer utilization (paragraph [0005]) which would contribute to the art, absent a clear showing of evidence to the contrary. Xing teaches a material that exhibits strong complexing ability with metals (paragraph [0021-0022]), provides a controlled-release coating for pesticides while reducing environmental pollution (see Xing [0005], claim 10) to suggest an improvement upon the non-water-soluble polymer of Tsivion (see Tsivion [013]). For the foregoing reasons the instant claims are rendered obvious by the teachings of the prior art. Response to Arguments Applicants’ arguments have been fully considered but they are not persuasive. Claim rejections 102 Applicant cite Rohrer, in column 1, lines 53-61, and column 2, lines 41-44, to argue that Rohrer teaches insoluble micronutrient and the instant disclosure of precipitate in applicants’ specification does not allow insoluble micronutrient. The Examiner respectfully submits that Rohrer teaches a formulation comprising high concentration of micronutrients with good rheological stability by incorporating a combination of polyelectrolytes with metal complexing agents. It is the “complexation of the soluble portion of nutrient ions that allows for increase compatibility with the other component in the formulation and rheology control” (column 2, lines 28-29). Additionally, Rohrer teaches that, “it is expected that the soluble micronutrient will be readily available to a plant , correcting any micronutrient deficiency, while the insoluble micronutrient will gradually convert to a soluble form over time” (column 4, lines 21-24). Claims 1-3 recite a formulation comprising an aqueous solution of metal ions. This is taught by the reference since some of the metal ions are dissolved in the water. The claim can further comprise additional ingredients that change the composition from a solution to a formulation that is not a solution. Rejections - 103 In response to applicant's argument that Xing does not teach the recited "for extending the activity of micronutrient based pesticides over a period of time," the Examiner respectfully notes that a recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. Whether Xing has a proclivity for fertilizers or not, it does not take away from Xing teaching polyacrylic acid (PAA) and polymethacrylic acid (PMAA) (paragraph [0018], claim 4). For these reasons, Applicants’ arguments are found unpersuasive. Conclusion All claims under consideration remain rejected; no claims are allowed. Applicants’ amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicants are reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no case, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Karen A. Ketcham whose telephone number is (571) 270-5896. The examiner can normally be reached M-F, 9-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ali Soroush can be reached at 571-272-9925. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Karen A Ketcham/Examiner, Art Unit 1614 /ALI SOROUSH/Supervisory Patent Examiner, Art Unit 1614
Read full office action

Prosecution Timeline

Feb 02, 2024
Application Filed
Jan 16, 2026
Non-Final Rejection mailed — §102, §103, §112
May 16, 2026
Response Filed
Sep 29, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12593838
STABLE AGROCHEMICAL COMPOSITION
3y 6m to grant Granted Apr 07, 2026
Patent 12533302
SYSTEMS AND METHODS FOR DELIVERY OF ACTIVES & HEALING TISSUE
3y 11m to grant Granted Jan 27, 2026
Patent 12508233
GRAFT COPOLYMERS, METHODS OF FORMING GRAFT COPOLYMERS, AND METHODS OF USE THEREOF
4y 8m to grant Granted Dec 30, 2025
Patent 12178800
SULFORAPHANE-MELATONIN-LIKE COMPOUND
3y 10m to grant Granted Dec 31, 2024
Patent 12097180
SWINE MATERNAL NEONATAL PHEROMONE
4y 0m to grant Granted Sep 24, 2024
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
21%
Grant Probability
61%
With Interview (+39.9%)
3y 6m (~9m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 57 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month